secwatch.observer — SEC 8-K summary
======================================

Issuer:     Cyclerion Therapeutics, Inc. (CYCN)
CIK:        0001755237
Form:       8-K
Filed at:   2023-06-27T23:59:59+00:00
Accession:  0000950170-23-030168
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

COO Cheryl Gault resigns; effective at close of asset sale to JW Celtics
------------------------------------------------------------------------

- Cheryl Gault resigned as COO effective on closing of the proposed sale of certain assets to JW Celtics Investment Corp.
- Separation agreement provides six months of base salary and COBRA subsidies; stock option exercise period extended to 24 months.
- Chairman Errol De Souza thanked Gault for her service to operations and the sale transaction.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1755237/000095017023030168/0000950170-23-030168-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1755237/000095017023030168/cycn-20230626.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-030168

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer